Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006360 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
A Phase 1 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006360: Completed Phase 1 study, sponsored by Radiation Therapy Oncology Group.
NCT00006360 is a Phase 1 study that has completed, run by Radiation Therapy Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006360, a Phase 1 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.
Interventions
- RADIATION radiation therapy
- DRUG radioprotection
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
What the finished NCT00006360 record still lists
NCT00006360 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00006360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006360 about?
NCT00006360 is a clinical study titled "Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.
What is the current status of trial NCT00006360?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00006360?
The interventions under investigation include: radiation therapy (RADIATION), radioprotection (DRUG).
Who is sponsoring clinical trial NCT00006360?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia